Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkaf1511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Kuan-Wei Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering Bioscience, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Phosphoproteins, DNA, Neoplasms. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Council, NSTC, National Health Research Institutes.
Abstract (Originalsprache)
In nucleic acid-binding proteins, short linear motifs (SLiMs)—an important subclass of intrinsically disordered regions (IDRs)—offer diverse opportunities for therapeutic intervention, yet their structural and functional roles remain largely elusive. Away from the active site of cancer immunotherapy target exonuclease TREX1, a novel modulation site formed by the intrinsically disordered α7–α8 loop is discovered by X-ray crystallography with newly identified inhibitors. Despite that the structure of α7–α8 loop upon binding-coupled disordered-to-ordered transition is inhibitor specific, a pattern of multivertex clamping is consistently observed. Mechanistically, the fuzzy TREX1–inhibitor interactions elucidated by structural analysis and molecular dynamics simulations reveal an ensemble of chemical-scale amphiphilic units for inhibitor moieties to anchor to. Functional assays confirm that our newly identified inhibitors disrupt the DNA binding and immunosuppressive activity of TREX1, establishing α7–α8 loop as a druggable SLiM. This work provides a first collection of atomic details for small-molecule inhibition involving a DNA-binding SLiM, and the mechanistic principles uncovered here may be generalized to targeting IDRs in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Engineering Bioscience, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.
- Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.
- Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu 30068, Taiwan.
- Department of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei City, Taiwan.
- Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11011, Taiwan.
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11011, Taiwan.
ORCID-Profile: Kuan-Wei Huang, I-Ya Chang, Helene Minyi Liu, Jhih-Wei Chu, Yu-Yuan Hsiao
Förderung
- National Science and Technology Council
- NSTC
- National Health Research Institutes
Zitieren
APA
Huang, K. W., Yu Tsai, C., Wu, C. Y., Lin, W. C., Wu, M. T., Hsu, K. C., Yu Yang, C., Chang, I. Y., Liu, H. M., Chu, J. W., & Hsiao, Y. Y. (2026). Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1511
Vancouver
Huang KW, Yu Tsai C, Wu CY, Lin WC, Wu MT, Hsu KC, et al. Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1511
BibTeX
@article{Huang2026,
author = {Huang, Kuan-Wei and Yu Tsai, Chieh- and Wu, Chia-Yun and Lin, Wei-Cheng and Wu, Meng-Tzu and Hsu, Kai-Cheng and Yu Yang, Chen- and Chang, I-Ya and Liu, Helene Minyi and Chu, Jhih-Wei and Hsiao, Yu-Yuan},
title = {Disordered DNA-binding motif forms a modulation site for inhibiting the cancer immunotherapy target TREX1},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkaf1511}
}
EUVIMED